<unk>  is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination<unk> /maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).
Atoltivimab
Odesivimab
Regdanvimab
Maftivimab
Sotrovimab
Obiltoxaximab
Nirsevimab
Bebtelovimab